Possibly because of a sex-dimorphic regulation of glucose homeostasis [25], women show an improved glycemic control, a greater peripheral and hepatic insulin sensitivity and a reduced HPG with respect to men [26,287,288], all features contributing to a lower susceptibility to NAFLD. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.